Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Completed · Phase 3
Conditions studied: Leukemia, Lymphoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which regimen of combination chemotherapy is more effective for acute lymphoblastic leukemia, lymphoblastic lymphoma, or chronic myelogenous leukemia. PURPOSE: This randomized phase III trial is studying two different chemotherapy regimens and comparing them to see how well they work in treating adults with acute lymphoblastic leukemia, lymphoblastic lymphoma, or chronic myelogenous leukemia.
Key facts
- Study ID
- NCT00002766
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 170
- Starts
- 1996-03-01
- Expected to finish
- 2011-09-01
- Last updated by the study team
- 2016-02-22
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
- Stanford Cancer Center at Stanford University Medical Center — Stanford, California, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- New York Medical College — Valhalla, New York, United States
- Duke Comprehensive Cancer Center — Durham, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.